Humana (NYSE:HUM) Updates FY 2024 Earnings Guidance

Humana (NYSE:HUM) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share guidance of 16.000-16.000 for the period, compared to the consensus earnings per share estimate of 16.360. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. UBS Group lowered their target price on shares of Humana from $334.00 to $326.00 and set a neutral rating for the company in a research note on Thursday, April 25th. TD Cowen lowered their price objective on shares of Humana from $427.00 to $396.00 and set a buy rating for the company in a research note on Tuesday, April 2nd. Oppenheimer lowered their price objective on shares of Humana from $415.00 to $370.00 and set an outperform rating for the company in a research note on Thursday, April 25th. Wells Fargo & Company lowered their price objective on shares of Humana from $413.00 to $350.00 and set an overweight rating for the company in a research note on Monday, April 8th. Finally, Jefferies Financial Group lowered their price objective on shares of Humana from $411.00 to $381.00 and set a buy rating for the company in a research note on Monday, April 22nd. Fourteen research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of Hold and a consensus price target of $409.55.

Humana Stock Performance

Shares of Humana stock opened at $361.09 on Thursday. The firm has a market cap of $43.51 billion, a PE ratio of 22.48, a price-to-earnings-growth ratio of 2.08 and a beta of 0.53. The firm’s 50-day simple moving average is $341.39 and its 200-day simple moving average is $354.08. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana has a 1 year low of $298.61 and a 1 year high of $530.54.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $9.38 EPS. Equities analysts forecast that Humana will post 16.12 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.98%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.